Neuroprotection in Huntington's [correction of Hungtington's] disease
Clin Neuropharmacol
.
2003 Sep-Oct;26(5):223-4; author reply 224.
doi: 10.1097/00002826-200309000-00001.
Authors
Theresa Lahousen
,
R M Bonelli
PMID:
14520158
DOI:
10.1097/00002826-200309000-00001
No abstract available
Publication types
Comment
Letter
MeSH terms
Animals
Humans
Huntington Disease / drug therapy*
Neuroprotective Agents / therapeutic use*
Substances
Neuroprotective Agents